Войти в систему Зарегистрироваться бесплатно

ProMIS Neurosciences прибыль на акцию

Что обозначает прибыль на акцию в ProMIS Neurosciences?

прибыль на акцию ProMIS Neurosciences, Inc. является -0.02

Какое определение для прибыль на акцию?



Прибыль на акцию (EPS) - это часть прибыли компании, распределяемая на каждую находящуюся в обращении обыкновенную акцию. Она скорректирована с учетом ослабления и рассчитана в течение двенадцати месяцев.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

прибыль на акцию компаний в Health Care сектор на TSX по сравнению с ProMIS Neurosciences

Что делает ProMIS Neurosciences?

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Компании с прибыль на акцию похож на ProMIS Neurosciences